See more : Medesis Pharma S.A. (ALMDP.PA) Income Statement Analysis – Financial Results
Complete financial analysis of Tribhovandas Bhimji Zaveri Limited (TBZ.BO) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Tribhovandas Bhimji Zaveri Limited, a leading company in the Luxury Goods industry within the Consumer Cyclical sector.
- The Phoenix Mills Limited (PHOENIXLTD.BO) Income Statement Analysis – Financial Results
- Aequus Pharmaceuticals Inc. (AQS.V) Income Statement Analysis – Financial Results
- Coop Opsparing Modig (COIMOD.CO) Income Statement Analysis – Financial Results
- Celltrion Healthcare Co., Ltd. (091990.KQ) Income Statement Analysis – Financial Results
- ETS Group Limited (8031.HK) Income Statement Analysis – Financial Results
Tribhovandas Bhimji Zaveri Limited (TBZ.BO)
About Tribhovandas Bhimji Zaveri Limited
Tribhovandas Bhimji Zaveri Limited designs, manufactures, retails, and sells jewelry primarily in India. Its products portfolio includes bangles, pendants, rings, necklaces, bracelets, earrings, and mangalsutras. The company also provides products in a various styles, such as gold, diamond studded, precious and semi-precious stone studded, and plain and diamond studded platinum; Lightweight and contemporary jewelry; jewelry with colored stones studded in gold; loose diamonds; solitaires; loose precious and semi-precious stones; and jadau jewelry. In addition, it is involved in franchise related business. Tribhovandas Bhimji Zaveri Limited was founded in 1864 and is based in Mumbai, India.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 22.99B | 23.93B | 18.44B | 13.42B | 18.10B | 17.64B | 17.51B | 16.90B | 16.55B | 19.34B | 18.24B | 16.58B | 13.80B | 11.94B |
| Cost of Revenue | 19.82B | 20.92B | 16.04B | 11.06B | 14.76B | 14.10B | 14.20B | 14.48B | 14.06B | 16.54B | 15.00B | 13.43B | 11.28B | 10.04B |
| Gross Profit | 3.17B | 3.01B | 2.39B | 2.36B | 3.34B | 3.53B | 3.31B | 2.41B | 2.48B | 2.80B | 3.24B | 3.16B | 2.52B | 1.90B |
| Gross Profit Ratio | 13.77% | 12.58% | 12.98% | 17.60% | 18.46% | 20.03% | 18.88% | 14.28% | 15.02% | 14.50% | 17.78% | 19.03% | 18.29% | 15.91% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 918.96M | 76.86M | 61.56M | 49.58M | 51.84M | 58.48M | 72.85M | 88.86M | 92.99M | 6.27M | 131.54M | 141.56M | 0.00 | 0.00 |
| Selling & Marketing | 428.87M | 449.79M | 340.44M | 151.00M | 321.21M | 396.68M | 411.29M | 301.27M | 532.12M | 633.15M | 454.76M | 550.12M | 0.00 | 0.00 |
| SG&A | 1.35B | 526.65M | 402.00M | 200.58M | 373.05M | 455.16M | 484.13M | 390.13M | 625.11M | 6.27M | 1.51B | 1.44B | 0.00 | 0.00 |
| Other Expenses | 0.00 | 2.74M | 3.73M | 2.20M | 4.33M | 6.04M | 15.25M | 6.27M | -23.96M | 0.00 | 0.00 | 0.00 | 350.86K | 222.90K |
| Operating Expenses | 1.35B | 2.00B | 1.80B | 1.33B | 2.45B | 2.80B | 2.57B | 1.77B | 2.05B | 2.06B | 2.00B | 1.73B | 1.34B | 1.08B |
| Cost & Expenses | 21.17B | 22.92B | 17.84B | 12.39B | 17.21B | 16.90B | 16.77B | 16.25B | 16.11B | 18.60B | 17.00B | 15.16B | 12.62B | 11.12B |
| Interest Income | 0.00 | 21.61M | 19.08M | 27.95M | 32.00M | 25.53M | 29.37M | 24.25M | 23.64M | 35.65M | 46.50M | 26.88M | 4.34M | 3.52M |
| Interest Expense | 498.24M | 428.38M | 317.97M | 433.83M | 510.84M | 43.26M | 354.12M | 466.13M | 518.73M | 461.09M | 431.77M | 215.82M | 315.03M | 224.69M |
| Depreciation & Amortization | 236.88M | 244.77M | 225.14M | 266.12M | 322.50M | 101.96M | 88.35M | 90.30M | 104.46M | 86.64M | 103.46M | 83.10M | 55.19M | 42.99M |
| EBITDA | 1.42B | 1.29B | 892.95M | 1.38B | 1.22B | 866.42M | 852.05M | 760.21M | 459.29M | 1.03B | 1.45B | 1.54B | 1.24B | 866.21M |
| EBITDA Ratio | 6.17% | 4.94% | 4.08% | 9.27% | 6.30% | 2.15% | 4.44% | 4.02% | 2.86% | 3.97% | 7.47% | 9.09% | 8.96% | 7.25% |
| Operating Income | 1.82B | 1.01B | 599.13M | 1.02B | 883.32M | 724.53M | 720.91M | 127.06M | -256.18M | 377.68M | 828.34M | 1.24B | 871.27M | 599.83M |
| Operating Income Ratio | 7.91% | 4.23% | 3.25% | 7.57% | 4.88% | 4.11% | 4.12% | 0.75% | -1.55% | 1.95% | 4.54% | 7.46% | 6.31% | 5.02% |
| Total Other Income/Expenses | -1.10B | -493.05M | -339.66M | -417.57M | -610.42M | -503.70M | -414.07M | -1.02B | -683.12M | -885.25M | -691.27M | -220.01M | -262.87M | -224.40M |
| Income Before Tax | 715.86M | 520.42M | 259.47M | 597.69M | 280.60M | 231.45M | 319.68M | 117.25M | -256.18M | 377.68M | 828.34M | 1.24B | 871.27M | 600.06M |
| Income Before Tax Ratio | 3.11% | 2.17% | 1.41% | 4.45% | 1.55% | 1.31% | 1.83% | 0.69% | -1.55% | 1.95% | 4.54% | 7.46% | 6.31% | 5.03% |
| Income Tax Expense | 171.59M | 118.52M | 57.65M | 165.02M | 66.45M | 75.81M | 107.08M | -12.04M | 19.27M | 134.49M | 278.36M | 392.38M | 298.84M | 208.20M |
| Net Income | 544.28M | 401.90M | 201.82M | 432.67M | 214.15M | 155.64M | 212.61M | 129.29M | -275.45M | 243.20M | 549.97M | 844.51M | 572.43M | 391.86M |
| Net Income Ratio | 2.37% | 1.68% | 1.09% | 3.22% | 1.18% | 0.88% | 1.21% | 0.77% | -1.66% | 1.26% | 3.01% | 5.09% | 4.15% | 3.28% |
| EPS | 8.16 | 6.02 | 3.02 | 6.48 | 3.21 | 2.33 | 3.19 | 1.94 | -4.13 | 3.65 | 8.25 | 12.95 | 11.45 | 7.84 |
| EPS Diluted | 8.16 | 6.02 | 3.02 | 6.48 | 3.21 | 2.33 | 3.19 | 1.94 | -4.13 | 3.64 | 8.24 | 12.94 | 11.43 | 7.82 |
| Weighted Avg Shares Out | 66.70M | 66.73M | 66.73M | 66.73M | 66.73M | 66.73M | 66.73M | 66.73M | 66.73M | 66.72M | 66.70M | 65.21M | 50.10M | 50.00M |
| Weighted Avg Shares Out (Dil) | 66.73M | 66.73M | 66.73M | 66.73M | 66.73M | 66.73M | 66.73M | 66.73M | 66.73M | 66.73M | 66.72M | 65.25M | 50.10M | 50.10M |
Source: https://incomestatements.info
Category: Stock Reports